Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcome of Corticosteroids in the Treatment of Chronic Obstructive Pulmonary Disease(COPD) Exacerbations in China (CONTAIN Study): Post-hoc Analysis of the Database of Acute Exacerbation of COPD Non-interventional Study

NCT03633838 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03633838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03633838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcome of Corticosteroids in the Treatment of Chronic Obstructive Pulmonary Disease(COPD) Exacerbations in China (CONTAIN Study): Post-hoc Analysis of the Database of Acute Exacerbation of COPD Non-interventional Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2017
Completion date
February 28, 2017
Enrollment
5,067 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of chronic obstructive pulmonary disease